Categories: Health

Charcot disease: After a twelve-year wait, a promising treatment finally sees the light of day

According to a recent study, scientists have discovered a cure for Charcot disease. After twelve years of research, the results show very promising data.

A glimmer of hope in the fight against Charcot disease. About one and a half hundred years ago, neurologist and professor of anatomy Dr Jean-Martin Charcot discovered amyotrophic lateral sclerosis (ALS), also called Charcot disease. As a reminder, this is a degenerative disease that affects neurons and causes muscle paralysis. To date, this pathology, which affects approximately 30,000 people in the United States, is incurable. However, researchers may have found a cure for ALS. A study published in a scientific journal found PLoS Biology

Experts have found a way to target and Stabilize proteins that protect cells from toxins from food or from inhaled oxygen.

Charcot disease: a promising new treatment

Often, Charcot disease patients have inherited mutations in a gene called SOD1, which causes the body to be unable to perform certain functions and disrupts cellular machinery. This forms a cluster of proteins that may also be associated with other diseases such as Parkinson’s or Alzheimer’s. So scientists have worked on a treatment that they describe “Molecular Stabilizer”. According to study director Jeffrey Agar, treatment a “stitch” Allows the protein to stay in its proper configuration. And if the researchers are so enthusiastic about testing their product, it is because the results shown on mice are very promising. Indeed, the molecule was tested on mice that had been genetically modified to carry the disease. The researchers then found that the treatment restored the protein’s functions.

Treatment of Charcot disease: human clinical trials soon?

But that’s not all! The treatment did not show any side effects in the rats. To verify its safety, the treatment was also tested on dogs and rats. Here again, the results are positive. It actually succeeded in stabilizing 90% of the SOD1 protein in blood cells and 60 to 70% in brain cells. In light of these figures, scientists now have only one thought: Begin clinical trials on humans. This may offer some hope to people with ALS.

You may also be interested in:

⋙ Here are the first symptoms of Charcot disease that are unmistakable!

⋙ Everything you need to know about Charcot disease: causes, symptoms, treatment, prevention

⋙ Parkinson: Could bacteria be the cause of this degenerative brain disease?

⋙ What if we diagnosed Alzheimer’s with a simple blood test?

⋙ Dementia or not: What’s the difference between “normal forgetfulness” and Alzheimer’s?

Source link

Admin

Share
Published by
Admin

Recent Posts

100 million degrees for 48 seconds: South Korea’s ‘artificial sun’ moves closer to nuclear revolution

This is a new record that scientists from the Korea Fusion Energy Institute (KFE) have…

6 months ago

The report offers solutions for insurers facing future growth in natural disasters

Damages associated with drought, floods, hail and other increasingly violent events are expected to increase…

6 months ago

You still have time to claim this exciting investigation

An estimated 9 million people in the United States are still waiting for their final…

6 months ago

IDF recognizes “serious mistake” in killing seven members of NGO World Central Kitchen

The death of seven humanitarian workers from the American NGO World Central Kitchen in an…

6 months ago

Fortnite Shop Apr 3, 2024 – Fortnite

Today, at one o'clock in the morning, Gamer updates it Boutique de Fortnite Through the…

6 months ago

Sharon Stone tried to make a Barbie movie in the 1990s

The Basic Instinct and Casino actress looks back at a time in Hollywood when adapting…

6 months ago